CAS 142279-42-3: Propanoic acid,2-[(1aR,1bS,2R,4aR,4bS,8aS,9R,9aS,10aR,10bS,10cS,11bS)-9-[(acetyloxy)methyl]-1a,1b,2,3,4a,6,8,8a,9,9a,10,10a,10b,10c,11,11b-hexadecahydro-2-hydroxy-7-(hydroxymethyl)-1b,10b-dimethyl-3,6-dioxocyclopropa[4,5]cyclopropa[4',5']cyclopent[1',2':7

Shizukaol D is a triterpenoid derivative, which is a secondary metabolite isolated from specific plant sources, notably within the Schisandraceae family. Its mode of action involves modulating various biological pathways, primarily through anti-inflammatory and antioxidant mechanisms. This compound has garnered scientific interest due to its unique structural attributes, which facilitate interactions with a range of cellular targets. The primary applications of Shizukaol D are within the pharmaceutical and biomedical research fields, where it is investigated for its potential therapeutic effects. Specifically, it shows promise in the development of treatments for conditions characterized by oxidative stress and inflammation, including certain chronic diseases and inflammatory disorders. By exploring its bioactive properties, researchers aim to elucidate the compound's role in mitigating pathophysiological processes and contributing to the development of novel therapeutic agents. Current studies continue to delve into its pharmacokinetics and bioavailability, aiming to better understand its efficacy and safety profile.

Shizukaol D exerts a growth inhibition effect on liver cancer cells in a dose- and time-dependent manner by modulating wnt signalling pathway.